Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Inpatient vs outpatient treatment management with teclistamab in relapsed and refractory multiple myeloma: A cost and healthcare resource utilization analysis

PaperCitations, authors & open-access status

Inpatient vs outpatient treatment management with teclistamab in relapsed and refractory multiple myeloma: A cost and healthcare resource utilization analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2025 year and bronze oa status.

1
Citations
2025
Year
bronze
OA Status

Related on ScholarIQ

Kirsten van Nimwegen
Author
Blood
Journal
Multiple Myeloma Research and Treatments
Topic
Multiple Myeloma Research and Treatments
Topic
CAR-T cell therapy research
Topic
vaccines and immunoinformatics approaches
Topic
470M+ articles · free account